{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T22:26:25Z","timestamp":1743459985875,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004828","name":"Grand Challenges Canada","doi-asserted-by":"publisher","award":["S4_0280-01","TTS-0709-05"],"award-info":[{"award-number":["S4_0280-01","TTS-0709-05"]}],"id":[{"id":"10.13039\/501100004828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2016CDF-1545"],"award-info":[{"award-number":["TMA2016CDF-1545"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3409-x","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:44:20Z","timestamp":1538563460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Peace","family":"Babirye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Musubika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Kirimunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Downing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian J","family":"Lutwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward K","family":"Mbidde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Weyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz T","family":"Paweska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses L","family":"Joloba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7239-8079","authenticated-orcid":false,"given":"Misaki","family":"Wayengera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"3409_CR1","first-page":"77","volume":"11","author":"H Feldmann","year":"1996","unstructured":"Feldmann H, Slenczka W, Klenk HD. Emerging and reemerging of filoviruses. Arch Virol Suppl. 1996;11:77\u2013100.","journal-title":"Arch Virol Suppl"},{"key":"3409_CR2","first-page":"1","volume":"13","author":"R Siegert","year":"1968","unstructured":"Siegert R, Shu HL, Slenczka HL, Peters D, Muller G. The aetiology of an unknown human infection transmitted by monkeys (preliminary communication). Ger Med Mon. 1968;13:1\u20132.","journal-title":"Ger Med Mon"},{"issue":"11","key":"3409_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000212","volume":"4","author":"JS Towner","year":"2008","unstructured":"Towner JS, Sealy TK, Khristova ML, CG A\u02dco, Conlan S, et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4(11):e1000212.","journal-title":"PLoS Pathog"},{"issue":"9","key":"3409_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJMoa051465","volume":"355","author":"DG Bausch","year":"2006","unstructured":"Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med. 2006;355(9):909\u201319.","journal-title":"N Engl J Med"},{"key":"3409_CR5","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s007050170049","volume":"146","author":"T Ikegami","year":"2001","unstructured":"Ikegami T, Calaor AB, Miranda ME, Niikura M, Saijo M, Kurane I, et al. Genome structure of Ebola virus subtype Reston: differences among Ebola subtypes. Arch Virol. 2001;146:2021\u20137.","journal-title":"Arch Virol"},{"issue":"4","key":"3409_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/femsre\/fuw010","volume":"40","author":"R Burk","year":"2016","unstructured":"Burk R, Bollinger L, Johnson JC, Wada J, Radoshitzky SR, Palacios G, Bavari S, Jahrling PB, Kuhn JH. Neglected filoviruses. FEMS Microbiol Rev. 2016;40(4):494\u2013519.","journal-title":"FEMS Microbiol Rev"},{"key":"3409_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.micinf.2005.04.006","volume":"7","author":"X Pourrut","year":"2005","unstructured":"Pourrut X, Kumulungui B, Wittmann T, Moussavou G, Delicat A, Yaba P, et al. The natural history of Ebola virus in Africa. Microbes Infect. 2005;7:1005\u201314.","journal-title":"Microbes Infect"},{"key":"3409_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1128\/CVI.13.4.444-451.2006","volume":"13","author":"M Saijo","year":"2006","unstructured":"Saijo M, Niikura M, Ikegami T, Kurane I, Kurata T, Morikawa S. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol. 2006;13:444\u201351.","journal-title":"Clin Vaccine Immunol"},{"key":"3409_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"SM Jones","year":"2005","unstructured":"Jones SM, Feldmann H, Str\u00f6her U, Geisbert JB, Fernando L, Grolla A, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nature Med. 2005;11:786\u201390.","journal-title":"Nature Med"},{"key":"3409_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee JE, MLl F, Hessell AJ, Oswald WB, Burton DR, et al. Structure of the ebola virus glycoprotein bound to an antibody from a human survivor. Nature. 2008;454:177.","journal-title":"Nature"},{"issue":"6","key":"3409_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/rmv.661","volume":"20","author":"TW Geisbert","year":"2010","unstructured":"Geisbert TW, Bausch DG, Feldmann H. Prospects for immunisation against Marburg and Ebola viruses. Rev Med Virol. 2010;20(6):344\u201357.","journal-title":"Rev Med Virol"},{"key":"3409_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.15585\/mmwr.mm6512a4","volume":"65","author":"JY Huang","year":"2016","unstructured":"Huang JY, Louis FJ, Dixon MG, Sefu M, Kightlinger L, Martel LD, et al. Notes from the field. Baseline assessment of use of Ebola rapid diagnostic tests\u2014Forecariah, Guniea, October-November 2015. MMWR Morb Mortal Rep. 2016;65:328\u20139.","journal-title":"MMWR Morb Mortal Rep"},{"issue":"4","key":"3409_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/CMR.00003-16","volume":"29","author":"MJ Broadhurst","year":"2016","unstructured":"Broadhurst MJ, Brooks TJG, Pollock NR. Diagnosis of Ebola virus disease: past, present and future. Clin Microbial Rev. 2016;29(4):773\u201393.","journal-title":"Clin Microbial Rev"},{"key":"3409_CR14","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/JVI.74.10.4933-4937.2000","volume":"74","author":"SY Chan","year":"2000","unstructured":"Chan SY, Speck RF, Ma MC, Goldsmith MA. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol. 2000;74:4933\u20137.","journal-title":"J Virol"},{"key":"3409_CR15","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1128\/JVI.73.10.8907-8912.1999","volume":"73","author":"H Ito","year":"1999","unstructured":"Ito H, Watanabe S, Sanchez A, Whitt MA, Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol. 1999;73:8907\u201312.","journal-title":"J Virol"},{"key":"3409_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/78654","volume":"6","author":"ZY Yang","year":"2000","unstructured":"Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med. 2000;6:886\u20139.","journal-title":"Nat Med"},{"issue":"Pt 5","key":"3409_CR17","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1099\/vir.0.81361-0","volume":"87","author":"N Alazard-Dany","year":"2006","unstructured":"Alazard-Dany N, Volchkova V, Reynard O, Carbonnelle C, Dolnik O, Ottmann M, et al. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J Gen Virol. 2006;87(Pt 5):1247\u201357.","journal-title":"J Gen Virol"},{"key":"3409_CR18","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","volume":"76","author":"SA Jeffers","year":"2002","unstructured":"Jeffers SA, Sanders DA, Sanchez A. Covalent modifications of the ebola virus glycoprotein. J Virol. 2002;76:12463\u201372.","journal-title":"J Virol"},{"key":"3409_CR19","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","volume":"95","author":"VE Volchkov","year":"1998","unstructured":"Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A. 1998;95:5762\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3409_CR20","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","volume":"93","author":"A Sanchez","year":"1996","unstructured":"Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A. 1996;93:3602\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3409_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1999.0110","volume":"268","author":"VE Volchkov","year":"2000","unstructured":"Volchkov VE, Volchkova VA, Stro\u00c8her U, Becker S, Dolnik O, Cieplik M, et al. Proteolytic processing of Marburg virus glycoprotein. Virol. 2000;268:1\u20136.","journal-title":"Virol"},{"key":"3409_CR22","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","volume":"23","author":"O Dolnik","year":"2004","unstructured":"Dolnik O, Volchkova V, Garten W, Carbonnelle C, Becker S, Kahnt J, et al. Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J. 2004;23:2175\u201384.","journal-title":"EMBO J"},{"key":"3409_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/viro.1997.8902","volume":"240","author":"A Sanchez","year":"1998","unstructured":"Sanchez A, Trappier S, Stroher U, Nichol S, Bowen M, Feldmann H. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virol. 1998;240:138\u201346.","journal-title":"Virol."},{"key":"3409_CR24","first-page":"45","volume":"47","author":"PY Chou","year":"1978","unstructured":"Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol. 1978;47:45\u2013148.","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"issue":"Web Server","key":"3409_CR25","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkn254","volume":"36","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008;36(Web Server):W513\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3409_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0020071","volume":"2","author":"B Korber","year":"2006","unstructured":"Korber B, LaBute M, Yusim K. Immunoinformatics comes of age. PLoS Comput Biol. 2006;2(6):e71.","journal-title":"PLoS Comput Biol"},{"key":"3409_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-2-2","volume":"2","author":"JEP Larsen","year":"2006","unstructured":"Larsen JEP, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2006;2:2.","journal-title":"Immunome Res"},{"key":"3409_CR28","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. In The Proteomics Protocols Handbook, edited by Walker JM. Humana Press; 2005: 571-607.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"3409_CR29","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul SF, Madden TL, Sch\u00e4ffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389\u2013402.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"3409_CR30","doi-asserted-by":"publisher","first-page":"D225","DOI":"10.1093\/nar\/gkq1189","volume":"39","author":"A Marchler-Bauer","year":"2011","unstructured":"Marchler-Bauer A, Zheng C, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, et al. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res. 2011;39(Database issue):D225\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3409_CR31","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1110\/ps.062405906","volume":"15","author":"P Haste Andersen","year":"2006","unstructured":"Haste Andersen P, Nielsen M, Lund O. Prediction of B-cell epitopes using protein 3D structures. Protein Sci. 2006;15(11):2558\u201367.","journal-title":"Protein Sci"},{"key":"3409_CR32","unstructured":"Wayengera M. Conserved B cell epitopes of filovirus glycoprotein and their use as either biomarkers or therapeutics and sub-unit vaccines for Ebola virus and marburg virus. World Intellecture Property Organization. 2016, International Application #:PCT\/IB2014\/066251: Pub #:WO\/2016\/079572 (Filing Date:21.11.2014)."},{"issue":"17","key":"3409_CR33","first-page":"4025","volume":"8","author":"M Wayengera","year":"2009","unstructured":"Wayengera M, Kajumbula H, Kaddu-Mulindwa D, Byarugaba W, Olobo J. Proteomics of Marburg and Ebola glycoproteins: insights into their physicochemical similarities and irregularities. Afr J Biotechnol. 2009;8(17):4025\u201331.","journal-title":"Afr J Biotechnol"},{"issue":"6202","key":"3409_CR34","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1126\/science.1259657","volume":"345","author":"SK Gire","year":"2014","unstructured":"Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369\u201372.","journal-title":"Science"},{"issue":"2","key":"3409_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/infdis\/jit162","volume":"208","author":"A Sobarzo","year":"2013","unstructured":"Sobarzo A, Groseth A, Dolnik O, Becker S, Lutwama JJ, Perelman E, et al. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). J Infect Dis. 2013;208(2):299\u2013309.","journal-title":"J Infect Dis"},{"key":"3409_CR36","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1128\/CVI.00363-12","volume":"19","author":"A Sobarzo","year":"2012","unstructured":"Sobarzo A, Perelman E, Groseth A, Groseth A, Dolnik O, Becker S, et al. Profiling the native specific human humoral immune response to Sudan ebolavirus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay. Clin Vaccine Immunol. 2012;19:1844\u201352.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"3409_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009126","volume":"5","author":"P Becquart","year":"2010","unstructured":"Becquart P, Wauquier N, Mahlakoiv T, Nkoghe D, Padilla C, Souris M, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One. 2010;5(2):e9126.","journal-title":"PLoS One"},{"issue":"5","key":"3409_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMc1300266","volume":"369","author":"A Sobarzo","year":"2014","unstructured":"Sobarzo A, Ochayon DE, Lutwama JJ, Balinandi S, Guttman O, Marks RS, et al. Persistent Immune Responses after Ebola Virus Infection. N Eng J Med. 2014;369(5):492\u20133.","journal-title":"N Eng J Med"},{"issue":"Suppl 1","key":"3409_CR39","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/514318","volume":"179","author":"AK Rowe","year":"1999","unstructured":"Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, et al. Clinical, Virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis. 1999;179(Suppl 1):S28\u201335.","journal-title":"J Infect Dis"},{"issue":"6","key":"3409_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001546","volume":"6","author":"A MacNeil","year":"2012","unstructured":"MacNeil A, Rollin PE. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis. 2012;6(6):e1546.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3409-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3409-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3409-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T23:07:14Z","timestamp":1605136034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3409-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3409"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3409-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study obtained ethical approval and clearance from the School of Biomedical Sciences Institutional Review and Ethics Committee (IREC), College of Health Sciences, Makerere University, Kampala, UG (Protocol Approval #s: SBS 138 and 228); as well as the Uganda National Council of Science and Technology (UNCST; Protocol Clearance # HR 1521). All samples used were broadly consented for future use, and a waiver consent was obtained from the Institutional Review and Ethics Committee (IREC) to re-use them in this work <i>The patient data were appropriately de-identified and anonymised, hence waiver of need for consent by the UVRI-Directorate and the SBS-IREC.<\/i>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u201cNot Applicable\u201d. This study used stored samples for which waiver approval was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MW has filed a PCT for these epitopes and derivative PAbs and Mabs (see: Wayengera M. Conserved B cell epitopes of filovirus glycoprotein and their use as either biomarkers or therapeutics and sub-unit vaccines for Ebola virus and marburg virus International Application #:PCT\/IB2014\/066251; Pub #:WO\/2016\/079572; Date:26.05.2016; Filing Date:21.11.2014). MW is Chief Scientific Officer at Restrizymes Biotherapeutics (U) LTD\u2014a Ugandan start-up biotech.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"498"}}